Straumann Holding AG completed the acquisition of 70% stake in Batigroup for CHF 8.1 million.
January 31, 2017
Share
Straumann Holding AG (SWX:STMN) agreed to acquire 70% stake in Batigroup for CHF 8.1 million on November 3, 2017. The remaining 30% of Batigroup will be held by the current owner, who will join the Straumann Group together with the company’s team of 200 employees. The deal also includes the distribution businesses for Straumann and Botiss products. As a result, the Straumann Group will control the distribution of all its brands in Turkey directly. The deal is approved by the Turkish Competition Authority. The transaction is expected to be completed by the end of January 2018.
Straumann Holding AG (SWX:STMN) completed the acquisition of 70% stake in Batigroup on January 1, 2018.
Straumann Holding AG is a Switzerland-based company active in the field of implant and restorative dentistry and oral tissue regeneration. In collaboration with clinics, research institutes and universities, the Group researches and develops implants, instruments, computer-aided design/manufacturing (CAD/CAM) prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann Holding AG also offers a range of services to the dental profession worldwide, including training and education, provided in collaboration with the International Team for Implantology (ITI). Its products and services are available in a number of countries through the Groupâs headquarters and through a network of subsidiaries and technology partners located in Europe, North America, the Asia/Pacific region and in Latin America, including Dental Wings Inc based in Canada and Createch Medical SL based in Spain.
STRAUMANN HOLDING AG 
